Cancer patient management: Current use of next-generation sequencing in the EU TOP4. (March 2023)
- Record Type:
- Journal Article
- Title:
- Cancer patient management: Current use of next-generation sequencing in the EU TOP4. (March 2023)
- Main Title:
- Cancer patient management: Current use of next-generation sequencing in the EU TOP4
- Authors:
- Hedblom, Amanda Hansson
Pruneri, Giancarlo
Quagliata, Luca
Costa, Jose Luis
Dumanois, Robert
Rolando, Chiara
Saunders, Rhodri - Abstract:
- Abstract: Background: Next-generation sequencing (NGS) is recognised by a growing audience of medical professionals as a functional diagnostic tool in oncology. However, adoption in clinical routine proceeds haphazardly in Europe. Methods: A semi-structured interview survey was administered to 68 cancer care professionals in four EU countries between June-August and November-December 2021. Pre-screening questionnaires assessed sufficient NGS expertise, diverse geographical distribution, and professional roles. Results: Our findings provide a better understanding of current clinical, regulatory, and reimbursement practices for NGS in four EU countries. Conclusions: Despite the impending European In-vitro Diagnostic Medical Devices Regulation (IVDR), tortuous national guidelines implementations and limping reimbursement policies are common traits across surveyed countries and produce disparity in access to advanced healthcare services amid regional distinctions. Policy summary: The evident information gap between involved parties and demand for consistent national guidelines could be filled by health economics analyses tailored to local specifics to provide factual leverage for a structured adoption of NGS testing. Highlights: Next-generation sequencing (NGS) has a growing diagnostic role in oncology. The adoption of NGS in clinical routine is impeded by uncertain policies. A semi-structured interview survey gave a better understanding of current practices in EU countries.Abstract: Background: Next-generation sequencing (NGS) is recognised by a growing audience of medical professionals as a functional diagnostic tool in oncology. However, adoption in clinical routine proceeds haphazardly in Europe. Methods: A semi-structured interview survey was administered to 68 cancer care professionals in four EU countries between June-August and November-December 2021. Pre-screening questionnaires assessed sufficient NGS expertise, diverse geographical distribution, and professional roles. Results: Our findings provide a better understanding of current clinical, regulatory, and reimbursement practices for NGS in four EU countries. Conclusions: Despite the impending European In-vitro Diagnostic Medical Devices Regulation (IVDR), tortuous national guidelines implementations and limping reimbursement policies are common traits across surveyed countries and produce disparity in access to advanced healthcare services amid regional distinctions. Policy summary: The evident information gap between involved parties and demand for consistent national guidelines could be filled by health economics analyses tailored to local specifics to provide factual leverage for a structured adoption of NGS testing. Highlights: Next-generation sequencing (NGS) has a growing diagnostic role in oncology. The adoption of NGS in clinical routine is impeded by uncertain policies. A semi-structured interview survey gave a better understanding of current practices in EU countries. Access disparities to advanced healthcare services are thought to be a result of uneven policies. … (more)
- Is Part Of:
- Journal of cancer policy. Volume 35(2023)
- Journal:
- Journal of cancer policy
- Issue:
- Volume 35(2023)
- Issue Display:
- Volume 35, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 35
- Issue:
- 2023
- Issue Sort Value:
- 2023-0035-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-03
- Subjects:
- Next-generation sequencing -- Policy -- European Union -- Cancer -- Diagnostics -- Survey
Cancer -- Government policy -- Periodicals
Cancer -- Patients -- Services for -- Periodicals
Medical Oncology -- Periodicals
Public Health -- Periodicals
Cancer
Periodicals
362.196994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22135383 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jcpo.2022.100376 ↗
- Languages:
- English
- ISSNs:
- 2213-5383
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26096.xml